The concept of strict product liability is addressed in “Product Liability: How It Turned Strict,” one of a series of articles for ID Access that address the legal risks faced by manufacturers and food distributors: “Under the new rule of strict liability, to hold a manufacturer liable, a person injured while using a product need only show that: (1) the product was defective; (2) it was used as intended; and (3) the defect caused the injury. The care used in the manufacture of the product is irrelevant to the determination of liability. The only issue in a product liability case is the defectiveness of the product, not the manufacturer’s conduct in somehow allowing the defect to arise. As a result, proof of negligence is not required to recover damages.”
Denis Stearns, is of-counsel at Marler Clark, earned a BA in philosophy from Seattle University, and his law degree from the University of Wisconsin at Madison. He graduated from both schools with high honors, and won numerous awards for service and
European Union reference laboratories focused on bacteria, parasites and viruses have started work.
Beginning this month, the three labs for foodborne and waterborne diseases officially began operations.
A group representing the fish sector in Europe has welcomed regulation on tuna frozen in brine.
Europêche said the legislation recognizes the high sanitary and technological standards already applied by
The Dutch poultry sector has implemented measures to try and curb a rise in Salmonella infections.
Figures show an increased incidence of Salmonella Enteritidis in laying hens since May 2023
The annual report of a system that helps ensure safe trade involving Europe has revealed the scale and reasons for rejected shipments.
TRACES is the online platform of the Directorate-General
OPINION
In an article that will soon be published in the Seattle Law Review, I take a look at food safety through the lens of the “pink slime” controversy and
“Ah, but a man’s reach should exceed his grasp, Or what’s a heaven for?”
— from Robert Browning’s “Andrea del Sarto”
Part 2: Does case law support FDA’
